|
[1] 杜艳萍,
朱汉民.
肌少症的诊疗和防治研究[J].
中华骨质疏松和骨矿盐疾病杂志,
2014, 7(1): 1-8.
[2] Stefan
D Anker, John E Morley, Stephan von Haehling. Welcome
to the ICD-10 code for sarcopenia[J]. J Cachexia, Sarcopenia and Muscle,
2016, 7(5): 512-514.
[3] 于宝海,
吴文娟.
2018 欧洲肌少症共识解读[J].
河北医科大学学报,
2019, 40(4): 373-379, 384.
[4] 李亚奥,
修双玲,
王立.
中老年男性2型糖尿病患者肌少症与骨密度的相关性研究[J].
首都医科大学学报,
2020, 41(1): 119-124.
[5] Tournadre
A, Vial G, Capel F, et al.
Sarcopenia[J]. Joint Bone Spine, 2019, 86(3): 309-314.
[6] 严淑,
陆亚华,
汪良芝.
老年肌少症的诊治和研究新进展[J].
中国老年学杂志,
2018, 38 (22): 5610-5613.
[7] Young
Nam Kwon, Sung-Sang Yoon. Sarcopenia:
neurological point of view[J]. J Bone Metabolism, 2017, 24(2): 83-89.
[8] Drey
M, Grösch C, Neuwirth C, et al. The
motor unit number index (MUNIX) in sarcopenic patients[J]. Experimental Gerontology,
2013, 48(4): 381-384.
[9] Mikael
Altun, Henrike C Besche, Herman Overkleeft, et
al. Muscle
wasting in aged, sarcopenic rats is associated with enhanced activity of the
ubiquitin proteasome pathway[J]. J Biological Chemistry, 2010, 285(51):
39597-39608.
[10] 王今越,
王小虹,
冯维斗.
IRS1, Akt, FOXO1在少肌症发生及其运动性缓解中的作用[J]. 成都体育学院学报,
2012, 38(7): 86-91.
[11] Sebastiaan
Dalle, Lenka Rossmeislova, Katrien Koppo. The
role of inflammation in age-related sarcopenia[J]. Frontiers in Physiology,
2017, 8: 1045.
[12] Laura
A Schaap, Saskia M F Pluijm, Dorly J H Deeg, et al. Higher
inflammatory marker levels in older persons: associations with 5-year change in
muscle mass and muscle strength[J]. J Gerontology Series A: Biomedical
Sciences and Medical Sciences, 2009, 64(11): 1183-1189.
[13] 王今越,
王小虹,
冯维斗.
p38, NF-κB, IL-6在少肌症发生及其运动性缓解中的作用[J]. 山东体育学院学报,
2012, 28(4): 51-56.
[14] 林白阳.
老年
COPD 患者血清
IL-6, IL-10水平与肌少症的关系[D].
太原：山西医科大学,
2019.
[15] Aphrodite
Vasilaki, Malcolm J Jackson. Role
of reactive oxygen species in the defective regeneration seen in aging muscle[J].
Free Radical Biology and Medicine, 2013, 65: 317-323.
[16] Adam
P W Johnston, Michael De Lisio, Gianni Parise. Resistance
training, sarcopenia, and the mitochondrial theory of aging[J]. Applied Physiology,
Nutrition, and Metabolism, 2007, 33(1): 191-199.
[17] Ramy
K A Sayed, Marisol Fernández-Ortiz, Maria E Diaz-Casado, et al. Lack
of NLRP3 inflammasome activation reduces age-dependent sarcopenia and
mitochondrial dysfunction, favoring the prophylactic effect of melatonin[J].
J Gerontology: Series A, 2019, 74(11): 1699-1708.
[18] 梁计陵,
谢金凤,
王岑依,
等.
运动诱导细胞自噬在老年肌少症康复中的研究进展[J].
中国康复理论与实践,
2019, 25(3): 334-337.
[19] Tomonori
Sato, Yoshiaki Ito, Takashi Nagasawa. L-Lysine
suppresses myofibrillar protein degradation and autophagy in skeletal muscles
of senescence-accelerated mouse prone 8[J]. Biogerontology, 2017, 18(1):
85-95.
[20] Richie
Barclay, Nicholas A Burd, Christopher Tyler, et al. The
role of the IGF-1 signalling cascade in muscle protein synthesis and anabolic
resistance in ageing skeletal muscle[J]. Frontiers in Nutrition, 2019, 6:
146.
[21] Silvia
Giovannini, Emanuele Marzetti, Stephen E Borst, et al. Modulation
of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults[J]. Mechanisms
of Ageing and Development, 2008, 129(10): 593-601.
[22] Mee-Sup
Yoon. mTOR
as a key regulator in maintaining skeletal muscle mass[J]. Frontiers in
Physiology, 2017, 8:788.
[23] Olivier
Le Bacquer, Kristell Combe, Veronique Patrac, et al. 4E-BP1
and 4E-BP2 double knockout mice are protected from aging-associated sarcopenia[J].
J Cachexia, Sarcopenia and Muscle, 2019, 10, 696-709.
[24] 金晶,
冯祎中,
黄伟,
等.
运动通过激活卫星细胞功能延缓和改善骨骼肌衰减症的研究进展[J].
体育科学,
2019, 39(8): 73-80.
[25] 卜凡.
耐力运动经AMPK介导的自噬维持老年小鼠骨骼肌卫星细胞干细胞属性[D].
重庆:
重庆医科大学,
2019.
[26] Parag
Kundu, Eran Blacher, Eran Elinav, et al. Our
gut microbiome: the evolving inner self[J]. Cell, 2017, 171(7): 1481-1493.
[27] Martina
Casati, Evelyn Ferri, Domenico Azzolino, et
al. Gut
microbiota and physical frailty through the mediation of sarcopenia[J].
Experimental Gerontology, 2019, 124: 110639.
[28] Melouane,
Aicha Ghanemi, Abdelaziz Yoshioka, et al. Functional
genomics applications and therapeutic implications in sarcopenia[J].
Mutation Research/Reviews in Mutation Research, 2019, 781, 175-185.
[29] Iryna
Rusanova, Jose Fernandez-Martinez, Marisol Fernandez-Ortiz, et al. Involvement
of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology
of frailty[J]. Experimental Gerontology, 2019, 124: 110637.
[30] Darren
G Candow, Scott C Forbes, Phillip D Chilibeck, et al. Variables
influencing the effectiveness of creatine supplementation as a therapeutic intervention
for sarcopenia[J]. Frontiers in Nutrition, 2019, 6: 124.
[31] Francisco
Martinez-Arnau, Fonfria-Vivas, Omar Cauli. Beneficial
effects of leucine supplementation on criteria for sarcopenia: a systematic review[J].
Nutrients, 2019, 11(10): 2504.
[32] Mareike
S Pötsch, Anika Tschirner, Sandra Palus, et
al. The
anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass
and decreases fat mass in old rats[J]. J Cachexia, Sarcopenia and Muscle,
2014, 5(2): 149-158.
[33] Peter
J Snyder, Helen Peachey, Peter Hannoush, et
al. Effect of
testosterone treatment on body composition and muscle strength in men over 65
years of age[J]. J Clinical Endocrinology &
Metabolism, 1999, 84(8): 2647-2653.
[34] Deepa
Sumukadas, Miles Witham, Allan D Struthers, et
al. Effect
of perindopril on physical function in elderly people with functional
impairment: a randomized controlled trial[J]. Cmaj, 2007, 177(8): 867-874.
[35] 魏静,
魏凯善,
罗敏,
等.
从“脾”论治肌肉减少症[J].
中医药临床杂志,
2019, 31 (7): 1282-1284.
[36] 毛智慧,
刘晓亭,
张欢,
等.
健运脾胃法干预老年肌肉衰减综合征之机理探讨[J].
辽宁中医杂志,
2017, 44(8): 1631-1634.
[37] 梁清月,
王仲,
刘戎,
等.
加减八珍汤联合营养支持治疗老年骨骼肌减少症疗效观察[J].
中国中西医结合杂志,
2019, 39(7): 821-825.
[38] 温春瑜,
陈颖颖,
彭鹏,
等.
补中益气汤加减辅助治疗老年肌少症的临床疗效观察[J].
实用中西医结合临床,
2018, 18(7): 72-73.
[39] 任璇璇,
姚惠,
汪涛.
八珍汤联合基础干预治疗老年肌少症临床疗效观察[J].
中国现代医生,
2016, 54(16): 127-130.
[40] 徐划萍,
金国琴,
龚张斌,
等.
补肾益气方药延缓骨骼肌衰老的实验研究[J].
中国临床药理学杂志,
2015, 31(1): 63-66.
[41] 王新梅.
天麻多糖延缓D-半乳糖诱导小鼠骨骼肌衰老的实验研究[D].
遵义：遵义医科大学,
2019.
[42] 李郡,
汪双双,
杨晓军,
等.
从86例处方浅谈邓铁涛教授治疗脾胃肌肉疾病用药规律特点[J].
时珍国医国药,
2015, 26(7): 1742-1743.
[43] 鲁飞翔.
肌肉衰减综合征小鼠模型的建立及相关分子和功能的评价[D].
锦州：锦州医科大学,
2017.
[44] 王丛丛.
尿石素
B 对地塞米松诱导的肌肉衰减综合征小鼠模型的影响[D].
锦州：锦州医科大学,
2018.
[45] 王月兵.
抗阻力运动结合肌酸补充对肌肉衰减综合征模型小鼠的影响[D].
锦州：锦州医科大学,
2017.
[46] 王全全.
人脐带华通氏胶间充质干细胞治疗肌肉衰减综合征的实验研究[D].
济南:
山东大学,
2018.
[47] 连雯雯,
刘艾林,
杜冠华.
DL0410改善D-半乳糖致衰老小鼠认知功能的线粒体保护机制研究[J].
神经药理学报,
2017, 7(02): 60.
[48] 王雪飞,
康金森.
香茅精油对D-半乳糖联合三氯化铝致老年痴呆小鼠的保护作用[J].
神经药理学报,
2017, 7(02): 38-39.
[49] 王婧.
D-半乳糖对肌肉衰减综合征的诱导效应和抗肌肉衰减因子研究[D].
北京：中国疾病预防控制中心,
2019.
[50] Mohammed
Mukhram Azeemuddin, Chamallamudi Mallikarjuna Rao, Mohamed Rafiq, et al. Pharmacological
investigation of ‘HIM-CHX’: A herbal combination in the experimental muscle
wasting condition[J]. Experimental Gerontology, 2019, 125: 110663.
[51] Meador
B M, Mirza K A, Tian M, et al. The green tea
polyphenol Epigallocatechin-3-Gallate (EGCg) attenuates skeletal muscle atrophy
in a rat model of sarcopenia[J]. The J Frailty & Aging, 2015, 4(4):
209-215.
[52] Deepa
Sathyaseelan, Holly Van Remmen, Susan V Brooks, et al. Accelerated
sarcopenia in Cu/Zn superoxide dismutase knockout mice[J]. Free Radical
Biology and Medicine, 2019, 132: 19-23.
|
